Bacil Pharma Ltd — Updates, 27-05-2025: Company Update

Bacil Pharma Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company reported total income of ₹8.77 lakh with a profit after tax of ₹1.56 lakh for the quarter. Comprehensive income stood at ₹1.56 lakh, while equity share capital was ₹1397.02 lakh. Earnings per share were 0.02. The results reflect modest profitability and stable equity base, indicating steady operational performance. This update is relevant for shareholders assessing the company’s short-term financial health and profitability trends.